Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway
Oncotarget · 06.01.2026 · 17 (1) · 180-181
DOI: 10.18632/oncotarget.28833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Tiantian Wang und 5 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, T., Wang, M., Fang, S., Wang, Q., Fang, R., & Chen, J. (2026). Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway. Oncotarget, 17(1), 180-181. https://doi.org/10.18632/oncotarget.28833
Vancouver
Wang T, Wang M, Fang S, Wang Q, Fang R, Chen J. Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway. Oncotarget. 2026;17(1):180-181. doi:10.18632/oncotarget.28833
BibTeX
@article{Wang2026,
author = {Wang, Tiantian and Wang, Mei and Fang, Shuang and Wang, Qiang and Fang, Rui and Chen, Jie},
title = {Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {180--181},
doi = {10.18632/oncotarget.28833}
}
EUVIMED